Investigational Drug Information for fluoruracil
✉ Email this page to a colleague
What is the drug development status for fluoruracil?
fluoruracil is an investigational drug.
There have been 29 clinical trials for fluoruracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2008.
The most common disease conditions in clinical trials are Breast Neoplasms, Colorectal Neoplasms, and Stomach Neoplasms. The leading clinical trial sponsors are University Hospital of Crete, Hellenic Oncology Research Group, and Gruppo Oncologico del Nord-Ovest.
Summary for fluoruracil
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 3,653 |
WIPO Patent Applications | 2,246 |
Japanese Patent Applications | 1 |
Clinical Trial Progress | Phase 3 (2008-03-01) |
Vendors | 5 |
Recent Clinical Trials for fluoruracil
Title | Sponsor | Phase |
---|---|---|
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma | Kuwait Cancer Control Center | Phase 3 |
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 1 |
Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients | Gruppo Oncologico Italiano di Ricerca Clinica | Phase 2 |
Clinical Trial Summary for fluoruracil
Top disease conditions for fluoruracil
Top clinical trial sponsors for fluoruracil
US Patents for fluoruracil
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |